Table 2.
Proteins expression in ovarian carcinoma.
| Protein | Threshold | Low expression, N (%) | High expression N (%) | NA |
|---|---|---|---|---|
| P53 | 90% | P53 Wild type54 (37%) | P53 abn92(63%) | 7 |
| Estrogen Receptor | 10% | 33 (19.3%) | 138 (80.7%) | 26 |
| Progesterone Receptor | 10% | 129 (66.5%) | 65 (33.5%) | 3 |
| PD-L1 | 1% | 121 (62.7%) | 72 (37.3%) | 4 |
| PTEN | 0% | 31 (16%) | 163 (84%) | 3 |
| p16 | 70% | 93 (48.7%) | 98 (51.3%) | 6 |
| EGFR | 0% | 162 (83.9%) | 31 (16.1%) | 4 |
| PMS2 | 10% | 2 (1%) | 189 (99%) | 5 |
| MSH2 | 10% | 1(0.5%) | 192(99.5%) | 4 |
| MSH6 | 10% | 3 (1.5%) | 190 (98.5%) | 4 |
| MLH1 | 10% | 3 (1.56%) | 189(98.4%) | 4 |
| ERBB2 | Score 0/1 vs. score 2/3 | 177 (91.2%) | 17 (8.8%) | |
| EZH2 | 15% | 98 (50.5%) | 96 (49.5%) | 3 |
| Gamma-H2AX | 10% | 109 (56.8%) | 83 (43.2%) | 5 |
N : number ; NA : not available ; abn : abnormal